Rildinadstrocel

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Structurally Diverse Created by `admin` on `Sat Dec 16 18:36:18 GMT 2023` Edited by `admin` on `Sat Dec 16 18:36:18 GMT 2023`
Source Materials Class	ORGANISM
Source Materials Type	ALLOGENIC HUMAN
Source Materials State	LIVE
Source Materials Parent	`G0T704E6Z3` HOMO SAPIENS WHOLE
Development Stage	ADULT
Part	ADIPOSE
Fraction Material Type	CELL
Fraction Name	MESENCHYMAL STEM
Record UNII	3ME9TTI5QB
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Rildinadstrocel

Official Name

English

PSC-04

Code

English

ASTROSTEM-V

Common Name

English

PSC-04 [WHO-DD]

Common Name

English

rildinadstrocel [INN]

Common Name

English

PSC-04 MCB

Code

English

COVI-MSC is an allogeneic culture-expanded adipose-derived mesenchymal stem cells derived from a disease-screened donor’s adipose tissue collected via liposuction and which undergoes tissue processing and manufacturing of the cell product under Good Ma

Common Name

English

RILDINADSTROCEL [USAN]

Common Name

English

ALLOGENEIC ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELLS (PSC-04)

Common Name

English

ALLOGENIC ADIPOSE DERIVED MESENCHYMAL STROMAL CELLS

Common Name

English

Astrostem-V [WHO-DD]

Common Name

English

ALLOGENIC ADIPOSE DERIVED MESENCHYMAL STEM CELLS (MSCS)

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

658218

Created by admin on Sat Dec 16 18:36:18 GMT 2023 , Edited by admin on Sat Dec 16 18:36:18 GMT 2023

FDA ORPHAN DRUG

427014

Created by admin on Sat Dec 16 18:36:18 GMT 2023 , Edited by admin on Sat Dec 16 18:36:18 GMT 2023

Code System Code Type Description

NCI_THESAURUS

C190749

Created by admin on Sat Dec 16 18:36:18 GMT 2023 , Edited by admin on Sat Dec 16 18:36:18 GMT 2023

PRIMARY

INN

12412

Created by admin on Sat Dec 16 18:36:18 GMT 2023 , Edited by admin on Sat Dec 16 18:36:18 GMT 2023

PRIMARY

USAN

JK-251

Created by admin on Sat Dec 16 18:36:18 GMT 2023 , Edited by admin on Sat Dec 16 18:36:18 GMT 2023

PRIMARY

FDA UNII

3ME9TTI5QB

Created by admin on Sat Dec 16 18:36:18 GMT 2023 , Edited by admin on Sat Dec 16 18:36:18 GMT 2023

PRIMARY

Related Record Type Details


					3ME9TTI5QB

Rildinadstrocel

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
ANTIGEN NOT EXPRESSED	BIOLOGICAL		`0X8U3V6C5K` MONOCYTE DIFFERENTIATION ANTIGEN CD14

PLASTIC ADHERENT	BIOLOGICAL

ANTIGEN EXPRESSED	BIOLOGICAL		`J4GH02V4K5` INTEGRIN BETA-1

ANTIGEN EXPRESSED	BIOLOGICAL		`EAD36Y912K` THY-1 MEMBRANE GLYCOPROTEIN

ANTIGEN EXPRESSED	BIOLOGICAL		`7KI95LX9LZ` CD44 ANTIGEN

ANTIGEN EXPRESSED	BIOLOGICAL		`T8635M4C7O` 5'-NUCLEOTIDASE

ANTIGEN NOT EXPRESSED	BIOLOGICAL		PLATELET ENDOTHELIAL CELL ADHESION MOLECULE (not present in database)
ANTIGEN NOT EXPRESSED	BIOLOGICAL		`FOR10CZY15` RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE C

ANTIGEN NOT EXPRESSED	BIOLOGICAL		`ZWL6BH0E0S` HEMATOPOIETIC PROGENITOR CELL ANTIGEN CD34

ANTIGEN NOT EXPRESSED	BIOLOGICAL		`PW3DO1LF7X` HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR (not present in database)